tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Invivyd’s Promising Position in the Antibody Market: Buy Rating Supported by Strong Data and Financial Growth
PremiumRatingsInvivyd’s Promising Position in the Antibody Market: Buy Rating Supported by Strong Data and Financial Growth
1M ago
Invivyd Raises $53.5 Million in Public Offering
Premium
Company Announcements
Invivyd Raises $53.5 Million in Public Offering
1M ago
Invivyd 50M share Spot Secondary priced at 52c
Premium
The Fly
Invivyd 50M share Spot Secondary priced at 52c
1M ago
Invivyd’s Transformative Year: Regulatory Advances and Market Potential Drive Buy Rating
PremiumRatingsInvivyd’s Transformative Year: Regulatory Advances and Market Potential Drive Buy Rating
1M ago
Invivyd Aligns with FDA for Rapid Approval Pathway
Premium
Company Announcements
Invivyd Aligns with FDA for Rapid Approval Pathway
1M ago
Invivyd aligns with FDA on pathway to approval of COVID-19 vaccine VYD2311
Premium
The Fly
Invivyd aligns with FDA on pathway to approval of COVID-19 vaccine VYD2311
1M ago
Invivyd’s VYD2311: Promising Phase 1/2 Trial Results and Strategic Positioning Support Buy Rating
PremiumRatingsInvivyd’s VYD2311: Promising Phase 1/2 Trial Results and Strategic Positioning Support Buy Rating
3M ago
Invivyd Announces Positive Phase 1/2 Trial Results
Premium
Company Announcements
Invivyd Announces Positive Phase 1/2 Trial Results
3M ago
Invivyd announces full Phase 1/2 clinical data for VYD2311
Premium
The Fly
Invivyd announces full Phase 1/2 clinical data for VYD2311
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100